• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[基于肾衰竭患者尿液中N-乙酰-β-D-氨基葡萄糖苷酶活性的近端肾小管功能障碍]

[Renal proximal disfunction based on activity of n-acetyl-beta-d-glucosaminidase in urine of patients with kidney failure].

作者信息

Szechiński J, Wiland P

机构信息

Zakład Reumatologii Akademii Medycznej, Okregowego Szpitala Kolejowego, Wrocławiu.

出版信息

Pol Arch Med Wewn. 1997 Dec;98(12):536-41.

PMID:9640082
Abstract

N-acetyl-beta-D-glucosaminidase (NAG) urine activities of 63 patients with stable and unstable chronic renal failure have been investigated. The values of NAG activity obtained from these patients were compared with NAG activity of 33 normal controls. Abnormal NAG values (> 70 nmol/mg of creatinine) were found in 60 (95.2%) patients with chronic renal failure and the median of all values was 327.8 nmol/mg of creatinine. It was 14-fold greater than the median of values for normal controls. There were any significant differences of NAG values between the patients with massive proteinuria (> 1.5 g/24 h), moderate proteinuria and those without 24 hour proteinuria or non-significant proteinuria (respectively 423.5 +/- 286.3 vs 414.4 +/- 334.8 vs 453.0 +/- 451.3 nmol/mg of creatinine). There was no significant difference between the two subgroups of patients with NAG values above and below 280 nmol/mg of creatinine in age, gender, serum urea and uric acid levels. However, the incidence of patients with NAG values higher than 280 nmol/mg of creatinine was statistically significant in unstable course of renal insufficiency and raised serum creatinine levels. It is suggested that the measurement of NAG excretion may be helpful to monitor unstable process in renal failure.

摘要

对63例稳定期和不稳定期慢性肾衰竭患者的尿N - 乙酰 -β - D - 氨基葡萄糖苷酶(NAG)活性进行了研究。将这些患者的NAG活性值与33名正常对照者的NAG活性进行了比较。在60例(95.2%)慢性肾衰竭患者中发现NAG值异常(>70 nmol/mg肌酐),所有值的中位数为327.8 nmol/mg肌酐。这比正常对照者值的中位数高14倍。大量蛋白尿(>1.5 g/24 h)患者、中度蛋白尿患者以及无24小时蛋白尿或微量蛋白尿患者的NAG值之间无显著差异(分别为423.5±286.3 vs 414.4±334.8 vs 453.0±451.3 nmol/mg肌酐)。NAG值高于和低于280 nmol/mg肌酐的两组患者在年龄、性别、血清尿素和尿酸水平方面无显著差异。然而,在肾功能不全的不稳定病程和血清肌酐水平升高时,NAG值高于280 nmol/mg肌酐的患者发生率具有统计学意义。提示测定NAG排泄量可能有助于监测肾衰竭的不稳定过程。

相似文献

1
[Renal proximal disfunction based on activity of n-acetyl-beta-d-glucosaminidase in urine of patients with kidney failure].[基于肾衰竭患者尿液中N-乙酰-β-D-氨基葡萄糖苷酶活性的近端肾小管功能障碍]
Pol Arch Med Wewn. 1997 Dec;98(12):536-41.
2
Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.在预测特发性膜性肾病的预后方面,β2微球蛋白优于N-乙酰-β-氨基葡萄糖苷酶。
Nephrol Dial Transplant. 2008 Aug;23(8):2546-51. doi: 10.1093/ndt/gfn007. Epub 2008 Feb 28.
3
[Effects of intravenous urography using sodium and meglumine ioxitalamate (Telebrix 38) on blood creatinine and urinary excretion of N-acetyl-beta-D-glucosaminidase].
Ann Biol Clin (Paris). 1984;42(6):407-11.
4
Early markers of renal dysfunction in patients with sickle cell/beta-thalassemia.镰状细胞/β地中海贫血患者肾功能障碍的早期标志物
Kidney Int. 2006 Jun;69(11):2037-42. doi: 10.1038/sj.ki.5000248.
5
Urinary N-acetyl-beta-D-glucosaminidase and neopterin aid in the diagnosis of rejection and acute tubular necrosis in initially nonfunctioning kidney grafts.尿N-乙酰-β-D-氨基葡萄糖苷酶和新蝶呤有助于诊断初始无功能肾移植中的排斥反应和急性肾小管坏死。
Nephron. 2000 Mar;84(3):228-35. doi: 10.1159/000045582.
6
Assessment of urinary N-acetyl-beta-D-glucosaminidase activity in geriatric cats with variable plasma creatinine concentrations with and without azotemia.对血浆肌酐浓度不同、有无氮血症的老年猫尿液中N-乙酰-β-D-氨基葡萄糖苷酶活性的评估。
Am J Vet Res. 2010 Feb;71(2):241-7. doi: 10.2460/ajvr.71.2.241.
7
Expression modes of urinary N-acetyl-beta-D-glucosaminidase in patients with chronic renal insufficiency.慢性肾功能不全患者尿N-乙酰-β-D-氨基葡萄糖苷酶的表达模式
Clin Chim Acta. 2004 Aug 16;346(2):129-33. doi: 10.1016/j.cccn.2004.01.006.
8
Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery.静脉注射N-乙酰半胱氨酸对接受心脏手术的慢性肾衰竭患者缺乏肾脏保护作用。
Br J Anaesth. 2006 Nov;97(5):611-6. doi: 10.1093/bja/ael224. Epub 2006 Aug 16.
9
Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome.肾损伤分子-1 和 N-乙酰-β-D-氨基葡萄糖苷酶在慢性心力衰竭中的作用:心肾综合征的潜在生物标志物。
Eur J Heart Fail. 2011 Oct;13(10):1104-10. doi: 10.1093/eurjhf/hfr102. Epub 2011 Aug 16.
10
Urinary excretion of N-acetyl-beta-D-glucosaminidase in proteinuric states.蛋白尿状态下N-乙酰-β-D-氨基葡萄糖苷酶的尿排泄情况。
Child Nephrol Urol. 1992;12(1):15-8.

引用本文的文献

1
Determination of Clara cell protein urinary elimination as a marker of tubular dysfunction.
Pediatr Nephrol. 2009 Apr;24(4):747-52. doi: 10.1007/s00467-008-1078-5. Epub 2009 Jan 17.